Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Many congratulations to Dr Qiang Zhang, Oxford BHF CRE Transition Fellow, who has won a prestigious award for his work in developing a groundbreaking technology for detecting scar in the myocardium

composite image showing powerpoint slide with qiang zhang photo and award information

Dr Qiang Zhang, deep learning scientist and a British Heart Foundation CRE fellow within OCMR and CVM, has won the Early Career Award (in the clinical category), at the Society for Cardiovascular Magnetic Resonance (SCMR) 25th Annual Scientific Sessions 2022

Dr Zhang received the award for his work titled “Development of Deep Learning Virtual Native Enhancement for Gadolinium-Free Myocardial Infarction and Viability Assessment”.

The current imaging gold-standard for detecting scar in the myocardium is a CMR scan that requires injection of a gadolinium-based contrast agent. Virtual Native Enhancement (VNE), invented by Dr Zhang with Prof. Stefan Piechnik, Prof. Vanessa Ferreira and their team, is a new artificial intelligence-based CMR technology for myocardial tissue characterisation that requires no gadolinium contrast and no needles.

 

I am very grateful for the fantastic mentorship and multi-disciplinary teamwork at OCMR which made this award possible. We aim to further develop AI solutions for faster and safer tests for heart conditions to improve patient care.
- Dr Qiang Zhang

 

VNE was previously validated in patients with hypertrophic cardiomyopathy, and has now been further developed for detecting scars from a previous heart attack (myocardial infarction). This new technique has enormous potential to replace conventional CMR scans for assessing other common cardiac pathologies. VNE can significantly reduce CMR scan time and costs, improve clinical practice, and expand the reach of CMR in the near future.

Similar stories

Unlocking the Secrets of cAMP Signalling in the Heart: A Pathway to Targeted Therapeutics

A new Zaccolo group study has revealed key new insights into the role of cAMP signalling in both healthy and disease settings within the heart. They have identified new cAMP nanodomains in cardiac muscle cells that have far reaching implications for the treatment of heart disease.

New blood test from DPAG cardiac researchers could save lives of heart attack victims

Researchers from the Herring group have developed a blood test that measures stress hormone levels after heart attacks. The test – costing just £10 – could ensure patients receive timely life-saving treatment.

Professor Barbara Casadei awarded 2022 Nylin Medal

The Swedish Society of Medicine has awarded the 2022 Nylin Medal to Professor Barbara Casadei, part of the Oxford BHF CRE leadership team.

Joaquim Vieira recognised in national image competition

DPAG BHF Intermediate Research Fellow Dr Joaquim Vieira has been shortlisted for the British Heart Foundation’s annual ‘Reflections of Research’ image competition.

Study develops radiotranscriptomic AI analysis to enable virtual heart biopsies

RDM researchers tested the method in COVID-19 patients, to find that the results predicted in-hospital mortality.